Is routine early invasive management of non-ST-segment elevation myocardial infarction beneficial in elderly patients?

Singh, Sheldon M.; Alter, David A.
October 2004
CMAJ: Canadian Medical Association Journal;10/26/2004, Vol. 171 Issue 9, p1046
Academic Journal
Discusses research being done on the use of routine early invasive management of non-ST-segment elevation myocardial infarction (STEMI) in elderly patients. Reference to a study by R. G. Bach and colleagues published in a 2004 issue of "Ann Intern Med"; Results of early invasive management of non-STEMI in ischemic patients; Examination of the benefits of early invasive management of non-STEMI for elderly patients.


Related Articles

  • Aortostial in-stent restenosis three months after primary percutaneous coronary intervention of the right coronary ostium in a patient presenting with cardiogenic shock. Hadžibegović, Irzal; Prvulović, Đeiti; Vujeva, Božo; Gabaldo, Krešimir // Cardiologia Croatica;Mar/Apr2013, Vol. 8 Issue 3/4, p111 

    Aortoostial lesions count for up to 3% of all pathologic findings on coronary angiography. Aortoostial stenting differs slightly from other anatomic sites, mostly because of the need for complete ostium coverage. Also, coronary ostia differ anatomically from other sites and are more prone to...

  • Study of Anti-Ischemic Effect of Afobazole in Experimental Myocardial Infarction. Kryzhanovskyi, S.; Sorokina, A.; Stolyaruck, V.; Vititnova, M.; Miroshkina, I.; Tsorin, I.; Durnev, A.; Seredenin, S. // Bulletin of Experimental Biology & Medicine;Sep2011, Vol. 150 Issue 3, p316 

    Seven-day treatment of rats with experimental myocardial infarction with afobazole (5-ethoxy-2-[2-morpholino)-ethylthio] benzimidasole dihydrochloride) resulted in shrinkage of the ischemic damage area in the heart, stimulation of reparative processes in the myocardium, and prevention of...

  • Scarring a necessary evil to prevent further damage after heart attack.  // Biomedical Market Newsletter;11/21/2011, Vol. 21, p641 

    The article reports on the result of the study which revealed that interrupting the scarring process to prevent damage after a heart attack can weaken heart function even further in the U.S. It mentions that researchers found that cells in the outer layer of the heart generated scar tissue. The...

  • Prevalence of Comorbidities and Their Impact on Hospital Management and Short-Term Outcomes in Vietnamese Patients Hospitalized with a First Acute Myocardial Infarction. Nguyen, Hoa L.; Nguyen, Quang Ngoc; Ha, Duc Anh; Phan, Dat Tuan; Nguyen, Nguyen Hanh; Goldberg, Robert J. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Cardiovascular disease is one of the leading causes of morbidity and mortality in Vietnam. We conducted a pilot study of Hanoi residents hospitalized with a first acute myocardial infarction (AMI) at the Vietnam National Heart Institute in Hanoi for purposes of describing the...

  • Guidelines-based treatments benefit elderly with MI.  // PharmacoEconomics & Outcomes News;6/13/2009, Issue 580, p6 

    The article discusses research being done on the use of guidelines-recommended treatments in the clinical management of myocardial infarction (MI) in elderly patients. It references a study by F. Schiele and colleagues, published in the April 2009 issue of the "European Heart Journal." The study...

  • Discovery may reduce heart injury.  // Asian Pacific Post;10/2/2008, p34 

    The article focuses on a new therapy developed by researchers at Singapore's Institute of Medical Biology and the Bioprocessing Technology Institute that improves post heart attack survival and recovery.

  • Tenecteplase shows equivalent 30-day mortality to alteplase.  // Formulary;Oct99, Vol. 34 Issue 10, p877 

    Compares the efficacy and safety of investigational fibrinolytic tenecteplase with front-loaded alteplase in their effect on 30-day mortality in patients with myocardial infarction. Number of patients involved in the study; Regimens; Median time from symptom onset to treatment; Equivalence of...

  • Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction. Grines, Cindy L.; Cox, David A.; Stone, Gregg W.; Garcia, Eulogio; Mattos, Luiz A.; Giambartolomei, Alessandro; Brodie, Bruce R.; Madonna, Olivier; Eijgelshoven, Marcel; Lansky, Alexandra J.; O'Neill, William W.; Morice, Marie-Claude // New England Journal of Medicine;12/23/99, Vol. 341 Issue 26, p1949 

    Background: Coronary-stent implantation is frequently performed for treatment of acute myocardial infarction. However, few studies have compared stent implantation with primary angioplasty alone. Methods: We designed a multicenter study to compare primary angioplasty with angioplasty accompanied...

  • Prasugrel. Duggan, Sean T.; Keating, Gillian M. // Drugs;2009, Vol. 69 Issue 12, p1707 

    Prasugrel (Efient®) is a potent, selective and irreversible inhibitor of adenosine diphosphate (ADP)-mediated platelet aggregation that is indicated for the prevention of atherothrombotic events in patients with acute coronary syndromes (ACS) [comprising unstable angina...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics